Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 150

1.

Looking forward to new targeted treatments for chronic spontaneous urticaria.

Kocatürk E, Maurer M, Metz M, Grattan C.

Clin Transl Allergy. 2017 Jan 10;7:1. doi: 10.1186/s13601-016-0139-2. Review.

2.

Masitinib for treatment of severely symptomatic indolent systemic mastocytosis: a randomised, placebo-controlled, phase 3 study.

Lortholary O, Chandesris MO, Livideanu CB, Paul C, Guillet G, Jassem E, Niedoszytko M, Barete S, Verstovsek S, Grattan C, Damaj G, Canioni D, Fraitag S, Lhermitte L, Lavialle SG, Frenzel L, Afrin LB, Hanssens K, Agopian J, Gaillard R, Kinet JP, Auclair C, Mansfield C, Moussy A, Dubreuil P, Hermine O.

Lancet. 2017 Feb 11;389(10069):612-620. doi: 10.1016/S0140-6736(16)31403-9.

PMID:
28069279
3.

A mutually beneficial collaboration between the European Academy of Allergy and Clinical Immunology Junior Members and Clinical and Translational Allergy.

Tomazic PV, Graessel A, Silva D, Eguiluz-Gracia I, Guibas GV, Grattan C, Bousquet J, Tsilochristou O.

Clin Transl Allergy. 2016 Dec 1;6:43.

4.

An update on mast cell disorders.

Cookson H, Grattan C.

Clin Med (Lond). 2016 Dec;16(6):580-583.

PMID:
27927825
5.

A new framework for the interpretation of IgE sensitization tests.

Roberts G, Ollert M, Aalberse R, Austin M, Custovic A, DunnGalvin A, Eigenmann PA, Fassio F, Grattan C, Hellings P, Hourihane J, Knol E, Muraro A, Papadopoulos N, Santos AF, Schnadt S, Tzeli K.

Allergy. 2016 Nov;71(11):1540-1551. doi: 10.1111/all.12939.

PMID:
27224838
6.

Reviewer acknowledgement 2015.

Grattan C.

Clin Transl Allergy. 2016 Apr 6;6:15. doi: 10.1186/s13601-016-0104-0. No abstract available.

7.

Definition, aims, and implementation of GA(2) LEN Urticaria Centers of Reference and Excellence.

Maurer M, Metz M, Bindslev-Jensen C, Bousquet J, Canonica GW, Church MK, Godse KV, Grattan CE, Hide M, Kocatürk E, Magerl M, Makris M, Meshkova R, Saini SS, Sussman G, Toubi E, Zhao Z, Zuberbier T, Gimenez-Arnau A.

Allergy. 2016 Aug;71(8):1210-8. doi: 10.1111/all.12901.

PMID:
27038243
8.

The definition, diagnostic testing, and management of chronic inducible urticarias - The EAACI/GA(2) LEN/EDF/UNEV consensus recommendations 2016 update and revision.

Magerl M, Altrichter S, Borzova E, Giménez-Arnau A, Grattan CE, Lawlor F, Mathelier-Fusade P, Meshkova RY, Zuberbier T, Metz M, Maurer M.

Allergy. 2016 Jun;71(6):780-802. doi: 10.1111/all.12884.

PMID:
26991006
9.

Making a dent with corticosteroid injections for de Quervain's tenosynovitis.

Khoo A, Grattan CE.

BMJ Case Rep. 2016 Feb 3;2016. pii: bcr2015214225. doi: 10.1136/bcr-2015-214225. No abstract available.

PMID:
26843225
10.

Work Productivity and Activity Impairment Among Chronic Spontaneous/Idiopathic Urticaria Patients: ResultsFrom The First International Burden of Illness Study (Assure-Csu).

Balp M, Chambenoit O, Chiva-Razavi S, Lynde C, Sussman G, Chapman-Rothe N, Weller K, Maurer M, Koenders J, Knulst AC, Halliday A, Alexopoulos ST, Nakonechna A, Grattan C, Abouzakouk M, Sweeney C, Radder C, Wolin D, McBride D, Hollis K, Tian H, Elberink JN.

Value Health. 2015 Nov;18(7):A427. doi: 10.1016/j.jval.2015.09.592. No abstract available.

11.

First Real-World Study Assessing Health Utility Values For Chronic Spontaneous/Idiopathic Urticaria Using The Eq-5d.

McBride D, Chambenoit O, Chiva-Razavi S, Lynde C, Sussman G, Chapman-Rothe N, Weller K, Maurer M, Koenders J, Knulst AC, Elberink JN, Halliday A, Alexopoulos ST, Nakonechna A, Abouzakouk M, Sweeney C, Radder C, Wolin D, Hollis K, Tian H, Balp M, Grattan C.

Value Health. 2015 Nov;18(7):A425. doi: 10.1016/j.jval.2015.09.578. No abstract available.

12.

Healthcare Resource Utilisation Among Chronic Spontaneous/Idiopathic Urticaria Patients- Findings From The First International Burden of Illness Study (Assure-Csu).

Tian H, Chambenoit O, Chiva-Razavi S, Lynde C, Sussman G, Chapman-Rothe N, Weller K, Koenders J, Knulst AC, Elberink JN, Halliday A, Alexopoulos ST, Nakonechna A, Grattan C, Abouzakouk M, Sweeney C, Radder C, Wolin D, McBride D, Hollis K, Balp M, Maurer M.

Value Health. 2015 Nov;18(7):A424. doi: 10.1016/j.jval.2015.09.576. No abstract available.

13.

Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology.

Hartmann K, Escribano L, Grattan C, Brockow K, Carter MC, Alvarez-Twose I, Matito A, Broesby-Olsen S, Siebenhaar F, Lange M, Niedoszytko M, Castells M, Oude Elberink JN, Bonadonna P, Zanotti R, Hornick JL, Torrelo A, Grabbe J, Rabenhorst A, Nedoszytko B, Butterfield JH, Gotlib J, Reiter A, Radia D, Hermine O, Sotlar K, George TI, Kristensen TK, Kluin-Nelemans HC, Yavuz S, Hägglund H, Sperr WR, Schwartz LB, Triggiani M, Maurer M, Nilsson G, Horny HP, Arock M, Orfao A, Metcalfe DD, Akin C, Valent P.

J Allergy Clin Immunol. 2016 Jan;137(1):35-45. doi: 10.1016/j.jaci.2015.08.034. Review.

PMID:
26476479
14.

ASSURE-CSU: a real-world study of burden of disease in patients with symptomatic chronic spontaneous urticaria.

Weller K, Maurer M, Grattan C, Nakonechna A, Abuzakouk M, Bérard F, Sussman G, Giménez-Arnau AM, Ortiz de Frutos J, Knulst A, Canonica GW, Hollis K, McBride D, Balp MM.

Clin Transl Allergy. 2015 Aug 17;5:29. doi: 10.1186/s13601-015-0072-9.

15.

Retrospective case note review of chronic spontaneous urticaria outcomes and adverse effects in patients treated with omalizumab or ciclosporin in UK secondary care.

Savic S, Marsland A, McKay D, Ardern-Jones MR, Leslie T, Somenzi O, Baldock L, Grattan C.

Allergy Asthma Clin Immunol. 2015 Jul 21;11(1):21. doi: 10.1186/s13223-015-0088-7.

16.

Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy.

Casale TB, Bernstein JA, Maurer M, Saini SS, Trzaskoma B, Chen H, Grattan CE, Gimenéz-Arnau A, Kaplan AP, Rosén K.

J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):743-50.e1. doi: 10.1016/j.jaip.2015.04.015.

17.

Diagnostic dilemmas in chronic urticaria.

Toubi E, Grattan C, Zuberbier T.

J Eur Acad Dermatol Venereol. 2015 Jun;29 Suppl 3:12-5. doi: 10.1111/jdv.13197.

PMID:
26053291
18.

An individualized diagnostic approach based on guidelines for chronic urticaria (CU).

Giménez-Arnau AM, Grattan C, Zuberbier T, Toubi E.

J Eur Acad Dermatol Venereol. 2015 Jun;29 Suppl 3:3-11. doi: 10.1111/jdv.13196.

PMID:
26053290
19.

Conservative management of a traumatic superficial temporal artery aneurysm.

Coelho RR, Grattan CE, Wilson P.

Clin Exp Dermatol. 2015 Dec;40(8):933-4. doi: 10.1111/ced.12645. No abstract available.

PMID:
25816895
20.

Reviewer acknowledgement 2014.

Grattan C.

Clin Transl Allergy. 2015 Feb 17;5:6. doi: 10.1186/s13601-015-0048-9.

Items per page

Supplemental Content

Support Center